NLRP3 and atherosclerosis: In the absence of infection or disease, NLRP3 activity is tightly regulated, whilst dysregulated activation is strongly associated with chronic inflammatory diseases (Chen et al., 2021), including atherosclerosis (Sharma et al., 2021) and neurodegeneration (Mondal et al., 2021).